Genetic clue to cause of high blood pressure

Abbott, Alison
June 1991
New Scientist;6/15/91, Vol. 130 Issue 1773, p23
Announces that Ken Bernstein, from Emory University and Tadashi Inagami of the Japanese company Kyowa Hakko Kogyo, have isolated a gene in rats that may cause high blood pressure. Cloning and identification of the molecular structure of the angiotensin receptor; Possible use of the cloned gene to develop new drugs for treating high blood pressure.


Related Articles

  • The coming epidemic: hypertension in rural Kyrgyzstan, Central Asia. Young, J. H.; Parler, P.; Bristol, B.; Klag, M. J. // Journal of Human Hypertension;Feb2005, Vol. 19 Issue 2, p145 

    Eastern Europe is experiencing an epidemic of cardiovascular disease far outpacing rates in Western Europe. This epidemic was heralded by a precipitous rise in hypertension prevalence. The former Soviet states of Central Asia may be facing a similar epidemic. In order to access this threat, we...

  • Telemetry or How to Increase the Efficacy of the Antihypertensive Treatment. Laszlo, M. I.; Kikeli, P. I.; Preg, Z.; Bocicor, Andreea // Acta Medica Marisiensis;Oct2010, Vol. 56 Issue 5, p457 

    Introduction: Hypertension is a cardiovascular risk factor which according to the SEPHAR study is therapeutically controlled in about 22.3% of patients. Therefore it is imperative to increase the efficiency of treatment in order to improve control of blood pressure. Material and methods: We...

  • Review: Combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure. Shantsila, Alena; Lip, Gregory Y. H.; Wald, D. S. // ACP Journal Club;8/18/2009, Vol. 151 Issue 2, p9 

    The article reports that combining 2 classes of blood pressure lowering drugs has an approximately additive effect on systolic blood pressure. In the trials, mean placebo-subtracted systolic BP reductions for monotherapies ranged from 6.8 mm Hg for ACE-Is to 9.3 mm Hg for BBsand reductions for...

  • Paracetamol raises BP risk.  // Pulse;3/8/2007, Vol. 67 Issue 9, p13 

    The article discusses the results of the study conducted by Gary Curhan of Harvard Medical School which show the potential of paracetamol to increase blood pressure. According to Curhan, the widespread use of medications and high prevalence of hypertension may have important public health...

  • Non-dipping BP 'needs aggressive therapy'.  // GP: General Practitioner;5/15/2009, p10 

    The article reports on a research of patients with resistant hypertension (RH). In this study, researchers performed 24-hour blood pressure (BP) monitoring on 556 patients with RH. The research suggested that patients whose BP does not fall overnight are at increased risk of adverse outcomes...

  • Best predictor of mortality is ambulatory BP.  // GP: General Practitioner;7/1/2005, p17 

    This article asserts that ambulatory blood pressure (BP) measurements are more useful than measurements taken in a clinic-type setting for predicting cardiovascular mortality. Over an eight-year follow-up period, the researchers recorded 646 deaths in the patient group. The researchers found...

  • Increasing the Validity and Efficiency of Blood Pressure Estimates Using Ambulatory and Clinic Measurements and Modern Missing Data Methods. Zawadzki, Matthew J.; Graham, John W.; Gerin, William // American Journal of Hypertension;Jul2012, Vol. 25 Issue 7, p764 

    BackgroundAmbulatory blood pressure monitoring (ABPM) is considered the gold standard for BP measurement, compared to clinic BP measurements (CBP), which are a less valid predictor of target organ damage and cardiovascular events. However, ABPM is considerably more expensive than CBP, leaving BP...

  • Blunted Morning BP Surges Raise Cardiovascular Risks.  // Renal & Urology News;Sep2012, Vol. 11 Issue 9, p29 

    The article cites a study about the association of blunted morning blood pressure (BP) surges on high risk of cardiovascular (CV) events among hypertensive patients that was reported in "Hypertension."

  • Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United States. Wolf-Maier, Katharina; Cooper, Richard S.; Banegas, José R.; Giampaoli, Simona; Hense, Hans-Werner; Joffres, Michel; Kastarinen, Mika; Poulter, Neil; Primatesta, Paola; Rodríguez-Artalejo, Fernando; Stegmayr, Birgitta; Thamm, Michael; Tuomilehto, Jaakko; Vanuzzo, Diego; Vescio, Fenicia // JAMA: Journal of the American Medical Association;5/14/2003, Vol. 289 Issue 18, p2363 

    Context: Geographic variations in cardiovascular disease (CVD) and associated risk factors have been recognized worldwide. However, little attention has been directed to potential differences in hypertension between Europe and North America. Objective: To determine whether higher blood pressure...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics